Synthetic Communications p. 1610 - 1621 (2017)
Update date:2022-08-17
Topics:
Suresh, Garbapu
Nadh, Ratnakaram Venkata
Srinivasu, Navuluri
Yennity, Durgaprasad
A new and efficient synthetic route for dual-Src/Abl kinase inhibitor dasatinib (Sprycel), an anticancer drug, is described. This commercially viable process yields dasatinib monohydrate free of potential impurities with consistent yield of 68% in route A and 61% in route B with HPLC purity >99.80% over four stages.
View MoreGuangZhe ANFA chemical co.,Ltd
Contact:86-579-87262335
Address:Guangzhe industrial area ,shaowu city ,Fujiang
Contact:17316303296
Address:240 Amboy Ave
HEZE KINGVOLT CHEMICAL CO., LTD
Contact:86-573-82118911
Address:Juancheng Industry Park
Nanjing Fubang Chemical Co.,Ltd
Contact:+86-25-83179199
Address:5F,Tianzheng international plaza,No399 Zhongyang Road ,Nanjing China
Changzhou Sunlight Pharmaceutical Co., Ltd.
Contact:+86-519-83131668;83139028;83138042;83137041
Address:JiuliStreet, Benniu Town Changzhou City, Jiangsu Province
Doi:10.1007/s11030-018-9875-7
(2019)Doi:10.1002/ejic.201701169
(2017)Doi:10.1021/j100328a043
(1988)Doi:10.1016/S0008-6215(00)90706-7
(1985)Doi:10.1016/S0040-4039(98)02335-1
(1998)Doi:10.1016/j.molstruc.2016.07.089
(2017)